| Field | Specification |
|---|---|
| Organism | |
| Applications | |
| Tissue | |
| Age | |
| Growth properties | |
| Biosafety level | |
| Product format | Frozen |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Overview
The Immortalized Human Cranial Periosteal Cell Line (TAg58) is the first human cranial periosteal cell line isolated from a healthy adult patient biopsy and immortalized by lentiviral transduction with the large SV40 T antigen. The following are key characteristics that have been observed for the Immortalized Human Cranial Periosteal Cell Line (TAg58) (Alexander et al., 2015): Maintains long-term cell proliferation and osteogenic differentiation potentialShows stronger calcium phosphate mineralization than parental primary cellsMaintains similar expression patterns for most surface antigens as parental primary cellsExpresses higher levels of stem cell surface markers, CD146, and MSCA-1 (mesenchymal stem cell antigen-1), as well as higher constitutive mRNA levels of key osteogenesis factors (e.g.
Key elements and design rationale
- Model identity: Immortalized Human Cranial Periosteal Cells (Tag58) is supplied as a tumor cell line derived from Human bone.
- Growth properties: Adherent, polygonal
- Growth conditions: For optimal cell culture, we recommend using PriCoat™ T25 Flasks (G299) or coating your preferred vessels with Applied Cell Extracellular Matrix (G422). PriGrow IV (TM004) + 2 mM L-glutamine (G275) + 10% FBS (Regular*) + 1% Penicillin/Streptomycin Solution (G255), 37.0°C, 5% CO₂ *Do not heat-inactivate
- Engineering / immortalization: Immortalized with lentivirus containing large SV40 T antigen
- Product format: Frozen, BSL-2
This cell-based model is generally used in cell fate, differentiation, and expansion studies. Donor/background information is available for contextual interpretation.
Biological background
Osteocalcin, alkaline phosphatase, runx-2) compared to parental primary cellsThe Immortalized Human Cranial Periosteal Cell Line (TAg58) represents a suitable experimental platform for studying periosteal cell biology, bone formation, and bone regeneration. Depositor Profile: Prof. Dr. Dorothea Alexander-Friedrich, University Hospital Tübingen In Germany alone, more than 10,000 people are newly diagnosed with oral cancer every year resulting in tumor and in the most cases jaw bone resection. In order to reconstruct the resulting bone defects, an alternative to autologous bone transplantation is needed. The research laboratory of the Department of Oral and Maxillofacial Surgery of the University Hospital Tübingen focuses its research on the field of bone tissue engineering (TE). Read how their work with jaw and cranial periosteal cells translate into the generation of 3D TE-constructs and lead the way to biocompatible stem cell-based therapies. Read full profile. Characterization by osteogenic differentiation experiments, Western blot, flow cytometry, detection of cell mineralization by fluorescent osteoImage staining, and gene expression analysis. Donor/background information provided for this product: Healthy adult patient biopsy.
Research relevance and current trends
- Cell-line models continue to be used for tumor phenotype comparison, pathway perturbation studies, and assay development in controlled in vitro systems.
- Engineered and subtype-defined tumor lines are often used to compare growth behavior, reporter output, and response patterns across matched experimental conditions.
- When metastatic or lineage features are described, investigators commonly interpret results alongside morphology, passage history, and culture environment.
Common research applications
- Cancer biology studies that compare proliferation-associated behavior, morphology, and pathway responses in vitro.
- Assay development for treatment response, reporter monitoring, or phenotype comparison under matched culture conditions.
- Side-by-side comparison of engineered versus parental background characteristics when relevant to the study design.
Changes in morphology, growth rate, viability, or reporter signal are typically interpreted together with passage history, culture matrix, and the specified growth conditions for the model.
Notes for experimental interpretation
- Morphology, doubling behavior, and reporter or marker output can shift with passage number, substrate choice, and medium composition; these variables should be recorded alongside experimental readouts.
- Matched controls such as parental cells, untreated cultures, or parallel cultures maintained under identical conditions help distinguish background effects from biology of interest.
Culture and product details
- Growth Conditions: For optimal cell culture, we recommend using PriCoat™ T25 Flasks (G299) or coating your preferred vessels with Applied Cell Extracellular Matrix (G422). PriGrow IV (TM004) + 2 mM L-glutamine (G275) + 10% FBS (Regular*) + 1% Penicillin/Streptomycin Solution (G255), 37.0°C, 5% CO₂ *Do not heat-inactivate
- Immortalization Method: Immortalized with lentivirus containing large SV40 T antigen
- Thaw cells quickly in a 37°C water bath while agitating gently (maximum 2 minutes). The vial cap should be kept above the water level to minimize the risk of contamination.
- Decontaminate the vial by spraying and wiping the exterior of the vial with 70% ethanol. From this point onwards, all operations should be strictly carried out inside a biological safety cabinet using aseptic conditions.
- Transfer the cell suspension into a 15ml sterile conical tube containing 5ml of pre-warmed, complete growth media. Centrifuge cells at 125xg for 5-7 minutes.
- Aspirate the supernatant without disturbing the cell pellet. Re-suspend the cell pellet in the recommended pre-warmed, complete growth media and dispense into a T25 culture flask.
- Incubate the cells at the recommended conditions.
- Aspirate the culture media, and add 2-3ml of pre-warmed 0.25% Trypsin-EDTA to the culture vessel.
- Observe the cells under a microscope to confirm detachment (typically within 2-10 minutes). Cells that are difficult to detach can be put in 37°C, for several minutes to facilitate detachment.
- Neutralize Trypsin-EDTA by adding an equal volume of the complete growth media into the culture vessel.
- Transfer the culture suspension into a sterile centrifuge tube, and centrifuge at 125xg for 5 minutes. The actual centrifuge duration and speed may vary depending on the cell type.
- Aspirate the supernatant, and re-suspend the pellet with pre-warmed fresh complete growth media. Add appropriate aliquots of the cell suspension to new culture vessels, as desired.
- Incubate the cells at the recommended conditions.
How should I handle live cells once I receive them?
https://www.abmgood.com/immortalized-cells-documents.html
Following these guidelines will help ensure optimal cell viability and performance.
Why are these cells classified as biosafety level II?
What is your warranty or return policy?
Please refer to the following link for full information:
https://www.abmgood.com/terms
For additional questions, our Order team is happy to assist and can be reached at order@abmgood.com.
How many times can cells divide?
Primary cells have a limited lifespan and will undergo a finite number of population doublings before entering senescence. The exact number varies by cell type and culture conditions.
Immortalized cell lines are capable of extended or indefinite proliferation under proper culture conditions, although growth characteristics may vary between lines.
Do I need Applied Cell Extracellular Matrix (G422) if I am using PriCoat™ flasks?
Cell line sourcing and selection (species, tissue, and disease model matching) · Stable cell line engineering (overexpression, knockdown, knockout via CRISPR/Cas9, shRNA, sgRNA) · Reporter gene integration (GFP, RFP, luciferase, fluorescent/bioluminescent constructs) · Genome editing and knockin (point mutations, tagged endogenous proteins, conditional alleles) · Inducible expression systems (Tet-On/Off and regulatable constructs) · Drug resistance marker selection (puromycin, G418, hygromycin, and others) · Custom growth and media optimisation for specific assay requirements · Scale-up production for high-throughput screening campaigns · Authentication and QC services (STR profiling, mycoplasma testing, viability assessment). Talk to a Scientist or contact support@biohippo.com.
